Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13233-40. eCollection 2015.

Abstract

Extramammary Paget's disease (EMPD) is a rare cutaneous neoplasm. The aim of this study was to elaborate the clinical and pathological features of Chinese EMPD male patients. The study comprised 246 patients with EMPD at our institute from January 1993 to December 2012. Scrotum was the most common initial site. The average age of onset was 63.9 years but the mean delay in diagnosis was 3.6 years. EPMD spread exclusively to the inguinal lymph nodes and the right inguinal lymph nodes are more likely to suffered Paget cells infiltration. Accompanying malignancies were found in 20 patients. Pathological examination revealed 63 patients defined as invasive EMPD. Immunohistochemical detection showed various expression levels of EMA, CEA, CK7, HER2/neu, Ki67, P53, CK20 and S100 in tumor tissues, but negative expression of VIM, LCA and HMB45. HER2/neu protein exhibited a significant association with invasive EMPD. A novel histological type of EMPD with CK7-/S100+ was identified. Elevated serum PSA level was observed in only 16% patients. Invasive EMPD often had advanced age of onset. Metastatic EMPD showed significantly shorter in the delay in diagnosis and the greater length of skin lesion in contrast to others. This study demonstrates the clinical and pathological features of Chinese male EMPD patients, and may provide implications for the management of Chinese EMPD patients.

Keywords: Extramammary Paget’s disease; invasion; metastases; pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism
  • China
  • Humans
  • Male
  • Middle Aged
  • Paget Disease, Extramammary / metabolism
  • Paget Disease, Extramammary / pathology*
  • Prognosis
  • Prostate-Specific Antigen / blood
  • Scrotum / metabolism
  • Scrotum / pathology*
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology*

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen